Abbott Laboratories
Outcome
OIG enforcement action against Abbott Laboratories for false claims, kickbacks. Penalty: $5.5 million.
Details
Abbott Laboratories — OIG Enforcement (2026)
OIG took enforcement action against Abbott Laboratories in 2026 involving false claims, kickbacks violations in the Independent Pharmacies sector.
Penalty: $5.5 million
Violation types: False Claims, Kickbacks
Entity type: Pharmacy
Penalty type: Settlement
Source: Abbott Laboratories Pays U.S. $5.475 Million to Settle Claims That Company Paid Kickbacks to Physicians
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works